Board Briefing >> CQC Assessment >> Board Accountability >> Standards & Cross-System Learning >> PSIRF Transition Services
Below are examples of how we can support your organisation through the transition. The italics are a sample of the new requirements your organisation will need to address.
1. Board Development – Engagement sessions to explore and consider strategies to embed new responsibilities and accountability. Understand the wider requirements and their inter-connectivity including CQC’s expectations.
Sample Requirements:
Trust boards (including board quality sub committees) will be held to account for the following:
Governors (where applicable) will be held to account as follows:
2. CEO Insight – Gain an understanding of the implications of specific accountabilities and support in identifying potential strategies for effective implementation and compliance.
Sample Requirements:
3. Risk, Governance & Patient Safety Teams Development – Independent and impartial advice for developing implementation plans, metrics and creation of engagement platform. Determine baseline data and identify key learning priorities for improvement cycles.
Sample Requirements:
4. Incident Investigation Priorities – Expert Incident Data Analysis – Impartial actuarial expertise and statistical analysis of clinical and risk management data. Outputs to identify where to best priorities for learning and improvement. Plans developed in conjunction with cost benefit analysis.
Sample Requirements:
5. PSIRF Gap Analysis – Resources, Process & Quality – Facilitate current and future state analysis of processes, resources and improvement strategies. Reviews designed to stress test current resources capabilities.
Sample Requirement:
6. PSIRF Implementation Strategy – Expert and impartial support in creating a bespoke, evidence based PSIRF Plan. Assist in preparation for Plan website publication, engagement and implementation.
Sample Requirements:
Using the following steps, develop a strategic plan to address the above findings:
7. Collaborative Learning: Cross-system Investigations – Engagement support to design positive, mutually beneficial sharing and learning processes working with Commissioners/STPs/ICSs/ICPs.
Sample Requirements:
Supporting cross-system patient safety investigations: (1) All commissioning systems (and/or STPs or ICSs/ICPs) must develop their capacity and capability, where are insufficient, for co- ordinating cross-system investigation and have systems to recognise incidents that extend beyond local boundaries and may require co- ordination at a regional level.
Regional Investigation teams will help co-ordinate cross-system PSIIs, primarily by working with commissioners (and/or STPs/ICSs/ICPs) to ensure they have the relevant systems to support these investigations at a local level and supporting co-ordinated and measured responses – both to take meaningful action against an incident’s causes and to meet the needs of those affected – to high profile or complex incidents. On occasion, regional teams will directly co-ordinate more complex, multi-organisation PSIIs where these cannot be managed at a local system level.
Testimonials | Consulting Services | Recent Projects |Expertise
Lorraine works with healthcare providers to identify and learn from risks to improve patient safety. Her work focusses on shaping systems and processes to provide early warnings for proactive risk management. Client programmes are anchored in the principles of engagement, transparency and leveraging data. Meaningful frontline engagement, using elements of Design Thinking, has enabled clients to better understand functional and cultural issues that inhibit learning.
Lorraine has applied this in Acute, Community and Mental Health settings. She has collaborated with the Stanford Risk Authority (of Stanford University Hospitals) for more than seven years focusing on innovative risk management processes.
Lorraine has worked in healthcare for almost 20 years and is a managing director of Price Forbes Healthcare. Lorraine holds a BA in Political Science and Economics.
Mark’s specialist clinical risk management knowledge centres around medical facilities including: Acute Hospitals, Mental Health and Community health including in Primary Care.
Mark has advised various Government bodies such as, Dept of Health and Ministry of Justice, by sitting on specially convened panels and industry sector groups to advise on clinical risk and indemnity, within the UK healthcare environment and similar healthcare economies across Europe.
Mark has worked closely with the healthcare regulators assisting these bodies in reviewing and assessing clinical risk, within all aspects of Healthcare, including public, private, not for profit and charitable sectors.
Mark is a managing director of Price Forbes Healthcare and read Law at Cambridge University, where he gained an MA.